Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
The Ukranian pharmaceutical market is expected to grow by 15% up to $3.3 billion in value terms this year, that will be the highest figure among the markets of other post-Soviet states, according to recent statements by some leading Ukranian analyst agencies in the field of pharmaceutics and local media reports. 30 December 2019
Pharmaceutical
Amid the ongoing stagnation of the Russian pharmaceutical market, local drugmakers have significantly increased exports of their drugs, according to recent statements, made by representatives of some leading local pharmaceutical producers and industry analysts, reports The Pharma Letter’s local correspondent. 24 December 2019
Pharmaceutical
Peru has been one of the leaders in Latin America in ensuring that there is a transparent relationship between the industry, medical community, patients and other groups. 17 December 2019
Pharmaceutical
The life sciences sector is in the news again in India and has entered the top league. The pharmaceuticals and healthcare sector recorded the second highest value of private equity and venture capital investments in November at $1.2 billion. This also happens to be the sector’s highest-ever value of private equity investment in a month, signalling the trajectory of the Indian life sciences industry, reports The Pharma Letter’s India correspondent. 17 December 2019
Pharmaceutical
The Russian government has officially approved a new procedure for commercialization of drugs in the national pharmaceutical market, according to recent statements made by some senior state officials of the Russian Ministry of Health and local analysts, reports The Pharma Letter’s local correspondent. 11 December 2019
Pharmaceutical
Indian pharma does not offer serious competition to multinationals in terms of vaccines. With the government coming up with compulsory annual healthcare programs in India, there is a huge market for vaccines which no Indian pharma company has been able to capture, reports The Pharma Letter’s India correspondent. 10 December 2019
Pharmaceutical
In her exclusive column for The Pharma Letter, this month, Dr Nicola Davies identifies progress being made within the therapeutic area of Klinefelter syndrome (KS), also known as 47,XXY or XXY. 6 December 2019
Pharmaceutical
Global drugmakers will continue to the use the policy of dumping in the Russian pharmaceutical market in years to come, in an attempt to get a better access to public procurements in Russia, according to recent statements by some local analysts in the field of pharmaceuticals and senior officials of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 3 December 2019
Generics
Israeli generics giant Teva Pharmaceutical Industries plans to significantly diversify its business and to expand into new sales markets during the next several years, according to recent statements made by Kåre Schultz, chief executive of the company. 3 December 2019
Pharmaceutical
Cancer patients in India have lauded the approval bagged by Roche from the Indian drug regulatory authority for Tecentriq (atezolizumab), a new treatment for extensive-stage small cell lung cancer (ES-SCLC). The drug was launched in India late last month, reports The Pharma Letter’s India correspondent. 3 December 2019
Biotechnology
Wuxi Biologics’ vaccine arm WuXi Vaccines (WV) expects to become a giant global vaccine supplier with its $240 million investment in the vaccine facility in Ireland last week, said the WuXi Vaccines chairman Chris Chen at a press meeting held on November 29 in Shanghai. 2 December 2019
Pharmaceutical
The Food and Drug Administration (FDA), under the strong leadership of Commissioner Dr Scott Gottlieb, moved into 2019 with a clear direction to address its most urgent priorities. 2 December 2019
Pharmaceutical
Multinationals pharmaceutical companies have cut prices significantly for some of the bestselling drugs in China to get covered by China’s newly-updated reimbursement drug list, effective on January 1 ,2020, reports The Pharma Letter’s local correspondent, Wang Fangqing. 29 November 2019
Generics
The Russian Intellectual Property Rights Court has upheld the decision of the previous court to provide the Russian generic drugmaker Nativa with a compulsory license on the production of an antitumor drug Sutent (sunitinib), which is originally produced by the USA’s Pfizer, reports The Pharma Letter’s local correspondent. 25 November 2019
Generics
India's war on drug prices has been pushed up another notch. Given that the list of drugs under price control has steadily expanded from 74 in 1995 to nearly 860 by 2019, the prevailing mood of the government is to further bring down prices. The price of drugs used to treat cancer and cardiac issues could soon face the axe, reports The Pharma Letter’s India correspondent. 19 November 2019
Pharmaceutical
The Russian government may postpone the introduction of controversial practice of mandatory labeling of drugs on the domestic pharmaceutical market (which is scheduled to come into force on January 1, 2020) for at least six months, according to recent statements of some senior state officials and members of the Russian Parliament (State Duma), reports The Pharma Letter’s local correspondent. 19 November 2019
Pharmaceutical
For Diabetes Awareness Month, Dr Nicola Davies, in her exclusive column for The Pharma Letter, examines progress being made with a rare form of the condition – monogenic diabetes. 18 November 2019
Pharmaceutical
The economic crises that have hit different parts of Latin America in recent months and years have threatened the progress of the pharmaceutical industry in some countries, but the sector's response is to stick together across the continent and keep coming up with innovative programs to serve patients. 15 November 2019
Pharmaceutical
As discussed in last month’s column, The FDA’s take on Medical Innovation, the US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) strives to support the innovation and development of novel drugs and biological products. 1 15 November 2019
Pharmaceutical
Russia may start large-scale of drugs on the African continent, that may take place within the next several years, according to recent statements made by the Russian Minister of Industry and Trade Denis Manturov as a result of the recent Russia-Africa forum, reports The Pharma Letter’s local correspondent. 12 November 2019
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Generics
Indian drugmaker Aurobindo Pharma has taken on the might of China in terms of Penicillin G pricing, and is doing so by leveraging a fully integrated production process at its new plant. Anticipating the price erosion of Penicillin G, the company has put up an integrated plant from scratch. 10 November 2024
Generics
Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new opportunities for India, especially in the pharmaceutical sector. 8 November 2024
Biotechnology
According to UNICEF's State of the World's Children 2023 report, in Latin America
and the Caribbean, 6.8 million children did not benefit from vaccination during the
time of the pandemic and in the following two years, progress has not been as
expected either. 7 November 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. 7 October 2024
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze